title: Dual-energy x-ray absorptiometry in osteopetrosis.
abstract: We have used dual-energy x-ray absorptiometry (DXA) in evaluation and follow-up of a patient with osteopetrosis, before and after cord blood transplantation. Other methods of follow-up in such cases have been described, but the use of DXA has not previously been reported. We have shown that DXA offers a safe means of assessing disease progression, the timing of treatment, and response after therapy for osteopetrosis.
authors.affiliation: Department of Radiology, Arkansas Children's Hospital, Little Rock, USA.
authors.forename: I N
authors.initials: IN
authors.lastname: Adler
authors.forename: K C
authors.initials: KC
authors.lastname: Stine
authors.forename: J
authors.initials: J
authors.lastname: Kurtzburg
authors.forename: D L
authors.initials: DL
authors.lastname: Kinder
authors.forename: K S
authors.initials: KS
authors.lastname: Cox
authors.forename: S Y
authors.initials: SY
authors.lastname: Lensing
authors.forename: J J
authors.initials: JJ
authors.lastname: Seibert
mesh_terms: D015502:Absorptiometry, Photon; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001803:Blood Transfusion; D018450:Disease Progression; D004872:Ergocalciferols / Q000627:therapeutic use; D005312:Fetal Blood; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007371:Interferon-gamma / Q000627:therapeutic use; D008297:Male; D010022:Osteopetrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D004872:Ergocalciferols; D007371:Interferon-gamma